Can surgeons improve survival in stage IV melanoma?

Journal of Surgical Oncology

Volumn 97, Issue 5, 2008, Pages 462-468

  Mosca, Paul J ^a   Teicher, Erik ^a   Nair, Suresh P ^a   Pockaj, Barbara A ^b  

^a LEHIGH VALLEY HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Advanced disease; Immunotherapy; Metastasis; Surgery; Systemic therapy

Indexed keywords

DACARBAZINE; MELANOMA VACCINE;

ANTINEOPLASTIC ACTIVITY; BRAIN METASTASIS; CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNOMODULATION; LUNG METASTASIS; MELANOMA; MICROMETASTASIS; OVERALL SURVIVAL; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; SKIN BIOPSY; SURGEON; SURVIVAL RATE; SURVIVAL TIME; VISCERAL METASTASIS;

CLINICAL TRIALS AS TOPIC; HUMANS; MELANOMA; NEOADJUVANT THERAPY; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 41549096417     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20950     Document Type: Review

References (61)

1. Balch CM, Buzaid AC, Soong SJ, et al.: Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635-3648.
2. Balch CM, Soong SJ, Gershenwald JE, et al.: Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622-3634.
3. Seung SK, Sneed PK, McDermott MW, et al.: Gamma knife radiosurgery for malignant melanoma brain metastases. Cancer J Sci Am 1998;4:103-109.
4. Yu C, Chen JC, Apuzzo ML, et al.: Metastatic melanoma to the brain: Prognostic factors after gamma knife radiosurgery. Int J Radiat Oncol Biol Phys 2002;52:1277-1287.
5. Lavine SD, Petrovich Z, Cohen-Gadol AA, et al.: Gamma knife radiosurgery for metastatic melanoma: An analysis of survival, outcome, and complications. Neurosurgery 1999;44:59-64.
6. Gonzalez-Martinez J, Hernandez L, Zamorano L, et al.: Gamma knife radiosurgery for intracranial metastatic melanoma: A 6-year experience. J Neurosurg 2002;97:494-498.
7. Becker G, Duffner F, Kortmann R, et al.: Radiosurgery for the treatment of brain metastases in renal cell carcinoma. Anticancer Res 1999;19:1611-1617.
8. Morton DL, Thompson JF, Kelly M, et al.: MMAIT-IV Clinical Trial Group. Multicenter double-blind phase 3 trial of Canvaxin vs placebo as post surgical adjuvant in metastatic melanoma. Presented at the Society of Surgical Oncology's 59th Annual Cancer Symposium, San Diego, California, March 23-26, 2006.
9. Hsueh EC, Essner R, Foshag LJ, et al.: Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine. J Clin Oncol 2002;20:4549-4554.
10. Hena MA, Emrich LJ, Nambisan RN, et al.: Effect of surgical treatment on stage IV melanoma. Am J Surg 1987;153:270-275.
11. Pogrebniak HW, Stovroff M, Roth JA, et al.: Resection of pulmonary metastases from malignant melanoma: Results of a 16-year experience. Ann Thorac Surg 1988;46:20-23.
12. Wong JH, Euhus DM, Morton DL: Surgical resection for metastatic melanoma to the lung. Arch Surg 1988;123:1091-1095.
13. Karp NS, Boyd A, DePan HJ, et al.: Thoracotomy for metastatic malignant melanoma of the lung. Surgery 1990;107:256-261.
14. Gorenstein LA, Putnam JB, Natarajan G, et al.: Improved survival after resection of pulmonary metastases from malignant melanoma. Ann Thorac Surg 1991;52:204-210.
15. Harpole DH, Jr., Johnson CM, Wolfe WG, et al.: Analysis of 945 cases of pulmonary metastatic melanoma. J Thorac Cardiovasc Surg 1992;103:743-748.
16. Ricaniadis N, Konstadoulakis MM, Walsh D, et al.: Gastrointestinal metastases from malignant melanoma. Surg Oncol 1995;4:105-110.
17. Ollila DW, Essner R, Wanek LA, et al.: Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch Surg 1996;131:975-979; 979-980.
18. The International Registry of Lung Metastases. Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 1997;113:37-49.
19. Fletcher WS, Pommier RF, Lum S, et al.: Surgical treatment of metastatic melanoma. Am J Surg 1998;175:413-417.
20. Ollila DW, Hsueh EC, Stern SL, et al.: Metastasectomy for recurrent stage IV melanoma. J Surg Oncol 1999;71:209-213.
21. Agrawal S, Yao TJ, Coit DG: Surgery for melanoma metastatic to the gastrointestinal tract. Ann Surg Oncol 1999;6:336-344.
22. Meyer T, Merkel S, Goehl J, et al.: Surgical therapy for distant metastases of malignant melanoma. Cancer 2000;89:1983-1991.
23. Leo F, Cagini L, Rocmans P, et al.: Lung metastases from melanoma: When is surgical treatment warranted? Br J Cancer 2000;83:569-572.
24. Aoyama T, Mastrangelo MJ, Berd D, et al.: Protracted survival after resection of metastatic uveal melanoma. Cancer 2000;89:1561-1568.
25. Wood TF, DiFronzo LA, Rose DM, et al.: Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival? Ann Surg Oncol 2001;8:658-662.
26. Dalrymple-Hay MJ, Rome PD, Kennedy C, et al.: Pulmonary metastatic melanoma: The survival benefit associated with positron emission tomography scanning. Eur J Cardiothorac Surg 2002;21:611-614.
27. Gutman H, Hess KR, Kokotsakis JA, et al.: Surgery for abdominal metastases of cutaneous melanoma. World J Surg 2001;25:750-758.
28. Hsueh EC, Gupta RK, Qi K, et al.: TA90 immune complex predicts survival following surgery and adjuvant vaccine immunotherapy for stage IV melanoma. Cancer J Sci Am 1997;3:364-370.
29. Capizzi PJ, Donohue JH: Metastatic melanoma of the gastrointestinal tract: A review of the literature. Compr Ther 1994;20:20-23.
30. Spanknebel K, Kaufman HL: Surgical treatment of stage IV melanoma. Clin Dermatol 2004;22:240-250.
31. Essner R, Lee JH, Wanek LA, et al.: Contemporary surgical treatment of advanced-stage melanoma. Arch Surg 2004;139:961-966.
32. Wong SL, Coit DG: Role of surgery in patients with stage IV melanoma. Curr Opin Oncol 2004;16:155-160.
33. Essner R: Surgical treatment of malignant melanoma. Surg Clin North Am 2003;83:109-156.
34. Keilholz U, Conradt C, Legha SS, et al.: Results of interleukin-2-based treatment in advanced melanoma: A case record-based analysis of 631 patients. J Clin Oncol 1998;16:2921-2929.
35. Brand CU, Ellwanger U, Stroebel W, et al.: Prolonged survival of 2 years or longer for patients with disseminated melanoma: An analysis of related prognostic factors. Cancer 1997;79:2345-2353.
36. Wronski M, Arbit E: Surgical treatment of brain metastases from melanoma: A retrospective study of 91 patients. J Neurosurg 2000;93:9-18.
37. Brega K, Robinson WA, Winston K, et al.: Surgical treatment of brain metastases in malignant melanoma. Cancer 1990;66:2105-2110.
38. Zacest AC, Besser M, Stevens G, et al.: Surgical management of cerebral metastases from melanoma: Outcome in 147 patients treated at a single institution over two decades. J Neurosurg 2002;96:552-558.
39. Balch CM, Soong SJ, Murad TM, et al.: A multifactorial analysis of melanoma. IV Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol 1983;1:126-134.
40. Eton O, Legha SS, Moon TE, et al.: Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol 1998;16:1103-1111.
41. Manola J, Atkins M, Ibrahim J, et al.: Prognostic factors in metastatic melanoma: A pooled analysis of Eastern Cooperative Oncology Group trials. J Clin Oncol 2000;18:3782-3793.
42. Koc M, McGregor J, Grecula J, et al.: Gamma knife radiosurgery for intracranial metastatic melanoma: An analysis of survival and prognostic factors. J Neurooncol 2005;71:307-313.
43. Ryan L, Kramar A, Borden E: Prognostic factors in metastatic melanoma. Cancer 1993;71:2995-3005.
44. Bedikian AY, Legha SS, Mavligit G, et al.: Treatment of uveal melanoma metastatic to the liver: A review of the M.D. Anderson Cancer Center experience and prognostic factors. Cancer 1995;76:1665-1670.
45. Unger JM, Flaherty LE, Liu PY, et al.: Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials. Cancer 2001;91:1148-1155.
46. Rose DM, Essner R, Hughes TM, et al.: Surgical resection for metastatic melanoma to the liver: The John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg 2001;136:950-955.
47. Haigh PI, Essner R, Wardlaw JC, et al.: Long-term survival after complete resection of melanoma metastatic to the adrenal gland. Ann Surg Oncol 1999;6:633-639.
48. Caputy GG, Donohue JH, Goellner JR, et al.: Metastatic melanoma of the gastrointestinal tract: Results of surgical management. Arch Surg 1991;126:1353-1358.
49. Dimick JB, Cattaneo SM, Lipsett PA, et al.: Hospital volume is related to clinical and economic outcomes of esophageal resection in Maryland. Ann Thorac Surg 2001;72:334-339.
50. Aimar E, Debernardi A, Tancioni F, et al.: Meningeal melanocytoma of the temporal lobe: An uncommon tumor in an unusual location: Case report. J Neurosurg Sci 2003;47:211-214.
51. Fong Y, Gonen M, Rubin D, et al.: Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg 2005;242:540-544.
52. Birkmeyer JD, Dimick JB, Staiger DO: Operative mortality and procedure volume as predictors of subsequent hospital performance. Ann Surg 2006;243:411-417.
53. Agarwala SS, Neuberg D, Park Y, et al.: Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): A trial of the Eastern Cooperative Oncology Group. Cancer 2004;100:1692-1698.
54. Kolmel KF, Grange JM, Krone B, et al.: Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival: An European Organization for Research and Treatment of Cancer cohort study on 542 patients. Eur J Cancer 2005;41:118-125.
55. Tagawa ST, Cheung E, Banta W, et al.: Survival analysis after resection of metastatic disease followed by peptide vaccines in patients with stage IV melanoma. Cancer 2006;106:1353-1357.
56. Lewis KD, Robinson WA, McCarter M, et al.: Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma. J Clin Oncol 2006;24:3157-3163.
57. Moschos SJ, Edington HD, Land SR, et al.: Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responses. J Clin Oncol 2006;24:3164-3171.
58. Yang JC, Abad J, Sherry R: Treatment of oligometastases after successful immunotherapy. Semin Radiat Oncol 2006;16:131-135.
59. Blander JM, Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006;440:808-812. Epub 2006 Feb 19.
60. D'Angelica M, Brennan MF, Fortner JG, et al.: Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg 1997;185:554-559.
61. Allen PJ, Kemeny N, Jarnagin W, et al.: Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 2003;7:109-115.